SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032248
Filing Date
2022-11-14
Accepted
2022-11-14 17:11:36
Documents
71
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 812111
2 ex31-1.htm EX-31.1 17237
3 ex31-2.htm EX-31.2 16932
4 ex32-1.htm EX-32.1 9406
  Complete submission text file 0001493152-22-032248.txt   4442843

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biaf-20220930.xsd EX-101.SCH 35917
6 XBRL CALCULATION FILE biaf-20220930_cal.xml EX-101.CAL 56625
7 XBRL DEFINITION FILE biaf-20220930_def.xml EX-101.DEF 176125
8 XBRL LABEL FILE biaf-20220930_lab.xml EX-101.LAB 320540
9 XBRL PRESENTATION FILE biaf-20220930_pre.xml EX-101.PRE 267839
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 524215
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41463 | Film No.: 221387539
SIC: 8731 Services-Commercial Physical & Biological Research